These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36905743)

  • 1. Intravenous thrombolysis for mild stroke: NIHSS 3-5 Versus NIHSS 0-2.
    Wang L; Li G; Hao Y; Hao M; Xiong Y
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107070. PubMed ID: 36905743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Thrombolysis is Effective in Mild Stroke Patients with an Admission NIHSS Score of 3 to 5.
    Zhang K; Han L
    Curr Neurovasc Res; 2023; 20(4):434-442. PubMed ID: 37909432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
    JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of statin pre-treatment with baseline stroke severity and outcome in patients with acute ischemic stroke and received reperfusion treatment: An observational study.
    Escudero-Martínez I; Matusevicius M; Pavia-Nunes A; Sevcik P; Nevsimalova M; Rand VM; Kõrv J; Cappellari M; Mikulik R; Toni D; Ahmed N
    Int J Stroke; 2023 Feb; 18(2):201-207. PubMed ID: 35403505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
    Huang P; Yi XY
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9710-9720. PubMed ID: 37916334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of functional outcome after symptomatic intracranial hemorrhage complicating intravenous thrombolysis: results from the SITS-ISTR.
    Tsivgoulis G; Palaiodimou L; Stefanou MI; Theodorou A; Kõrv J; Nunes AP; Candelaresi P; Dall'Ora E; Sariaslani P; Provinciali L; Conforto AB; Cidrao AAL; Karapanayiotides T; Ahmed N
    Eur J Neurol; 2023 Oct; 30(10):3161-3171. PubMed ID: 37410547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolysis + endovascular thrombectomy versus thrombolysis alone in large vessel occlusion mild stroke: a propensity score matched analysis.
    Schwarz G; Bonato S; Lanfranconi S; Matusevicius M; Ghione I; Valcamonica G; Tsivgoulis G; Paiva Nunes A; Mancuso M; Zini A; Candelaresi P; Rand VM; Comi GP; Mazya MV; Ahmed N
    Eur J Neurol; 2023 May; 30(5):1312-1319. PubMed ID: 36746650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in minor stroke patients treated with intravenous thrombolysis.
    Duan C; Xiong Y; Gu HQ; Wang S; Yang KX; Hao M; Zhao X; Meng X; Wang Y
    CNS Neurosci Ther; 2023 Aug; 29(8):2308-2317. PubMed ID: 36942504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose statins improve prognosis of ischemic stroke patients with intravenous thrombolysis.
    Cui C; Li Y; Bao J; Dong S; Gao L; He L
    BMC Neurol; 2021 Jun; 21(1):220. PubMed ID: 34107911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thrombolysis versus antiplatelet therapy in minor stroke patients with large vessel occlusion.
    Duan C; Xiong Y; Gu H; Wang S; Yang KX; Hao M; Feng X; Zhao X; Meng X; Wang Y
    CNS Neurosci Ther; 2023 Jun; 29(6):1615-1623. PubMed ID: 36880290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and early outcomes after intravenous thrombolysis in acute ischemic stroke patients with prestroke disability.
    Cooray C; Karlinski M; Kobayashi A; Ringleb P; Kõrv J; Macleod MJ; Dixit A; Azevedo E; Bladin C; Ahmed N
    Int J Stroke; 2021 Aug; 16(6):710-718. PubMed ID: 32878588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
    Schlemm L; Braemswig TB; Boutitie F; Vynckier J; Jensen M; Galinovic I; Simonsen CZ; Cheng B; Cho TH; Fiehler J; Puig J; Thijs V; Fiebach J; Muir K; Nighoghossian N; Ebinger M; Pedraza S; Thomalla G; Gerloff C; Endres M; Lemmens R; Nolte CH;
    Neurology; 2022 Jan; 98(3):e302-e314. PubMed ID: 34782419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke.
    Zhai M; Yang J; Cao X; Li Y; Xu H; Wang Y
    Clin Appl Thromb Hemost; 2023; 29():10760296231187616. PubMed ID: 37461226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.
    Mazya MV; Lees KR; Collas D; Rand VM; Mikulik R; Toni D; Wahlgren N; Ahmed N
    Neurology; 2015 Dec; 85(24):2098-106. PubMed ID: 26546630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.